Cary, NC, Jan. 12, 2022 (Globe NEWSWIRE) — APIE Therapeutics, a preclinical biopharma company groundbreaking microvasculature endothelium drug improvement by focusing on the apelin receptor
Cary, NC, Jan. 12, 2022 (Globe NEWSWIRE) — APIE Therapeutics, a preclinical biopharma company groundbreaking microvasculature endothelium drug improvement by focusing on the apelin receptor
